Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

ClinicalTrials.gov ID: NCT00943072

Public ClinicalTrials.gov record NCT00943072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Masked, Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor Trap-Eye in Subjects With Macular Edema Secondary to Central Retinal Vein Occlusion

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3 study to determine the efficacy of VEGF Trap-Eye injected into the eye on vision function in subjects with macular edema as a consequence of central retinal vein occlusion.

Study identification

NCT ID
NCT00943072
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
189 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2009
Primary completion
Sep 30, 2010
Completion
Mar 31, 2012
Last update posted
May 26, 2013

2009 – 2012

United States locations

U.S. sites
46
U.S. states
23
U.S. cities
44
Facility City State ZIP Site status
Not listed Phoenix Arizona 85014
Not listed Phoenix Arizona 85020
Not listed Tucson Arizona 85704
Not listed Arcadia California 91007
Not listed Beverly Hills California 90211
Not listed La Jolla California 92037
Not listed Mountain View California 94040
Not listed Oakland California 94609
Not listed Sacramento California 95841
Not listed Torrance California 90503
Not listed New London Connecticut 06320
Not listed Altamonte Springs Florida 32701
Not listed Fort Lauderdale Florida 33334
Not listed Fort Myers Florida 33907
Not listed Fort Myers Florida 33912
Not listed Miami Florida 33143
Not listed Palm Beach Gardens Florida 33410
Not listed Winter Haven Florida 33880
Not listed Augusta Georgia 30909
Not listed Chicago Illinois 60612
Not listed Wichita Kansas 67214
Not listed Baltimore Maryland 21209
Not listed Hagerstown Maryland 21740
Not listed Towson Maryland 21204
Not listed Boston Massachusetts 02114
Not listed Grand Rapids Michigan 49525
Not listed Jackson Michigan 48104
Not listed Lincoln Nebraska 68506
Not listed Las Vegas Nevada 89135
Not listed Northfield New Jersey 08225
Not listed Toms River New Jersey 08755
Not listed Rochester New York 14620
Not listed Winston-Salem North Carolina 27157
Not listed Cleveland Ohio 44195
Not listed Oklahoma City Oklahoma 73104
Not listed Portland Oregon 97210
Not listed Salem Oregon 97302
Not listed Kingston Pennsylvania 18704
Not listed Pittsburgh Pennsylvania 15213
Not listed West Columbia South Carolina 29169
Not listed Rapid City South Dakota 57701
Not listed Nashville Tennessee 37203
Not listed Abilene Texas 79606
Not listed Fort Worth Texas 76102
Not listed Houston Texas 77030
Not listed San Antonio Texas 78240

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00943072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 26, 2013 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00943072 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →